Fig. 3From: Safety of new DAAs for chronic HCV infection in a real life experience: role of a surveillance network based on clinician and hospital pharmacistFigure represents percentage of Total Adverse Drug Reactions on the whole treated patients according to antiviral regimens. Detailed data on absolute number can be found in Table. Sofosbuvir plus Simeprevir was the regimen with more frequently reported common ADRBack to article page